Comment
doi: 10.1016/j.jhep.2022.04.039.
Epub 2022 May 17.
Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
Affiliations
- PMID: 35594993
- DOI: 10.1016/j.jhep.2022.04.039
Item in Clipboard
Comment
Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
J Hepatol.
2022 Nov.
No abstract available
Keywords: Fibrosis; PBC; PPAR delta; Seladelpar; UDCA.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!".J Hepatol. 2022 Nov;77(5):1452-1453. doi: 10.1016/j.jhep.2022.07.024. Epub 2022 Aug 14. J Hepatol. 2022. PMID: 35977610 No abstract available.
Comment on
-
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.J Hepatol. 2022 Aug;77(2):353-364. doi: 10.1016/j.jhep.2022.02.033. Epub 2022 Mar 30. J Hepatol. 2022. PMID: 35367282 Clinical Trial.
Similar articles
-
[Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].Zhonghua Gan Zang Bing Za Zhi. 2019 Jan 20;27(1):73-76. doi: 10.3760/cma.j.issn.1007-3418.2019.01.018. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 30685931 Chinese.
-
Hepatocellular Carcinoma in Primary Biliary Cholangitis.Clin Liver Dis. 2022 Nov;26(4):691-704. doi: 10.1016/j.cld.2022.06.011. Clin Liver Dis. 2022. PMID: 36270724 Review.
-
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
-
Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.Dig Dis Sci. 2023 Feb;68(2):346-348. doi: 10.1007/s10620-022-07661-y. Epub 2022 Sep 13. Dig Dis Sci. 2023. PMID: 36098875 No abstract available.
-
Obeticholic acid for the treatment of primary biliary cholangitis.Expert Opin Pharmacother. 2016 Sep;17(13):1809-15. doi: 10.1080/14656566.2016.1218471. Epub 2016 Aug 9. Expert Opin Pharmacother. 2016. PMID: 27468093 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
